<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127207/" ref="ordinalpos=726&amp;ncbi_uid=3069275&amp;link_uid=PMC3127207" image-link="/pmc/articles/PMC3127207/figure/F2/" class="imagepopup">Figure 2.  From: Luteolin Regulation of Estrogen <span class="highlight" style="background-color:">Signaling</span> and Cell Cycle <span class="highlight" style="background-color:">Pathway</span> Genes in MCF-7 Human Breast Cancer Cells. </a></div><br /><div class="p4l_captionBody"><b>Luteolin Effects on Estrogen Signaling Pathway (ESP) Genes.</b> Ingenuity Analysis of microarray data from MCF-7 cells treated with estradiol (controls) or estradiol + luteolin for 5 hours. Genes in this pathway were significantly (p&lt;0.01) upregulated by luteolin (light blue symbols) or estradiol (shaded symbols) or significantly (p&lt;0.01) downregulated by luteolin (gray symbols) or estradiol (dotted symbols). These data are numerically summarized in Table 2.</div></div>